Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and raises the price target from $2 to $5.
Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and raises the price target from $2 to $5.